| Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer Z Zhang, RC Bast Jr, Y Yu, J Li, LJ Sokoll, AJ Rai, JM Rosenzweig, ... Cancer research 64 (16), 5882-5890, 2004 | 1313 | 2004 |
| Circulating tumor DNA analysis in patients with cancer: American Society of Clinical Oncology and College of American Pathologists joint review JD Merker, GR Oxnard, C Compton, M Diehn, P Hurley, AJ Lazar, ... Archives of pathology & laboratory medicine 142 (10), 1242-1253, 2018 | 948 | 2018 |
| Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 … GS Omenn, DJ States, M Adamski, TW Blackwell, R Menon, H Hermjakob, ... Proteomics 5 (13), 3226-3245, 2005 | 935 | 2005 |
| HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples AJ Rai, CA Gelfand, BC Haywood, DJ Warunek, J Yi, MD Schuchard, ... Proteomics 5 (13), 3262-3277, 2005 | 612 | 2005 |
| A smartphone dongle for diagnosis of infectious diseases at the point of care T Laksanasopin, TW Guo, S Nayak, AA Sridhara, S Xie, OO Olowookere, ... Science translational medicine 7 (273), 273re1-273re1, 2015 | 475 | 2015 |
| Proteomic approaches to tumor marker discovery: identification of biomarkers for ovarian cancer AJ Rai, Z Zhang, J Rosenzweig, I Shih, T Pham, ET Fung, LJ Sokoll, ... Archives of pathology & laboratory medicine 126 (12), 1518-1526, 2002 | 335 | 2002 |
| Serum mesothelin for diagnosing malignant pleural mesothelioma: an individual patient data meta-analysis K Hollevoet, JB Reitsma, J Creaney, BD Grigoriu, BW Robinson, ... Journal of clinical oncology 30 (13), 1541-1549, 2012 | 256 | 2012 |
| Molecular biomarkers in localized prostate cancer: ASCO guideline SE Eggener, RB Rumble, AJ Armstrong, TM Morgan, T Crispino, ... Journal of Clinical Oncology 38 (13), 1474-1494, 2020 | 194 | 2020 |
| Effects of preanalytical variables on peptide and protein measurements in human serum and plasma: implications for clinical proteomics AJ Rai, F Vitzthum Expert review of proteomics 3 (4), 409-426, 2006 | 141 | 2006 |
| Cancer proteomics: serum diagnostics for tumor marker discovery AJ Rai, DW Chan Annals of the New York Academy of Sciences 1022 (1), 286-294, 2004 | 111 | 2004 |
| Introduction to urinalysis: historical perspectives and clinical application G Echeverry, GL Hortin, AJ Rai The urinary proteome: methods and protocols, 1-12, 2010 | 103 | 2010 |
| Analytical validation of the GeXP analyzer and design of a workflow for cancer-biomarker discovery using multiplexed gene-expression profiling AJ Rai, RM Kamath, W Gerald, M Fleisher Analytical and bioanalytical chemistry 393, 1505-1511, 2009 | 101 | 2009 |
| Analysis of Human Proteome Organization Plasma Proteome Project (HUPO PPP) reference specimens using surface enhanced laser desorption/ionization‐time of flight (SELDI‐TOF … AJ Rai, PM Stemmer, Z Zhang, B Adam, WT Morgan, RE Caffrey, ... Proteomics 5 (13), 3467-3474, 2005 | 101 | 2005 |
| An optimized procedure for exosome isolation and analysis using serum samples: application to cancer biomarker discovery M Li, AJ Rai, GJ DeCastro, E Zeringer, T Barta, S Magdaleno, ... Methods 87, 26-30, 2015 | 95 | 2015 |
| Novel serum and urine markers for pediatric appendicitis AB Kharbanda, AJ Rai, Y Cosme, K Liu, PS Dayan Academic Emergency Medicine 19 (1), 56-62, 2012 | 91 | 2012 |
| Smartphone dongle for simultaneous measurement of hemoglobin concentration and detection of HIV antibodies T Guo, R Patnaik, K Kuhlmann, AJ Rai, SK Sia Lab on a Chip 15 (17), 3514-3520, 2015 | 82 | 2015 |
| Types of assays for SARS-CoV-2 testing: a review MC Smithgall, M Dowlatshahi, SL Spitalnik, EA Hod, AJ Rai Laboratory medicine 51 (5), e59-e65, 2020 | 79 | 2020 |
| Quality control practices for chemistry and immunochemistry in a cohort of 21 large academic medical centers MW Rosenbaum, JG Flood, SEF Melanson, NA Baumann, MA Marzinke, ... American journal of clinical pathology 150 (2), 96-104, 2018 | 58 | 2018 |
| Artifactual isoform profile modification following treatment of human plasma or serum with protease inhibitor, monitored by 2-dimensional electrophoresis and mass spectrometry MD Schuchard, RJ Mehigh, SL Cockrill, GT Lipscomb, JD Stephan, ... Biotechniques 39 (2), 239-247, 2005 | 41 | 2005 |
| Comparison of laboratory-developed tests and FDA-approved assays for BRAF, EGFR, and KRAS testing AS Kim, AN Bartley, JA Bridge, S Kamel-Reid, AJ Lazar, NI Lindeman, ... JAMA oncology 4 (6), 838-841, 2018 | 39 | 2018 |
